0,904  0,005  Cyclophilin D inhibitor
0,904  0,005  Antidiabetic
0,876  0,002  Antimutagenic
0,868  0,004  Antihypercholesterolemic
0,852  0,003  Cholesterol antagonist
0,844  0,003  Antihypoxic
0,846  0,005  Caspase 9 stimulant
0,835  0,002  Alpha-N-acetylglucosaminidase inhibitor
0,843  0,010  Antiinflammatory
0,834  0,001  Amylase inhibitor
0,835  0,003  Angiogenesis stimulant
0,836  0,005  Chemoprotective
0,811  0,004  Cardioprotectant
0,808  0,004  Hypoglycemic
0,788  0,003  Sulfotransferase substrate
0,785  0,004  Antioxidant
0,770  0,011  Teratogen
0,758  0,004  NOS3 expression inhibitor
0,754  0,003  Aldose reductase substrate
0,756  0,006  Mutagenic
0,754  0,010  TNF expression inhibitor
0,755  0,011  Embryotoxic
0,748  0,005  5 Hydroxytryptamine release stimulant
0,739  0,007  Sensitization
0,732  0,005  UGT1A9 substrate
0,721  0,009  Chemopreventive
0,715  0,007  Antithrombotic
0,713  0,006  NOS2 expression inhibitor
0,708  0,010  Respiratory analeptic
0,708  0,019  Transcription factor NF kappa B inhibitor
0,685  0,004  Genotoxic
0,709  0,029  Apoptosis agonist
0,681  0,005  Free radical scavenger
0,676  0,004  Monophenol monooxygenase inhibitor
0,676  0,007  Proliferative diseases treatment
0,661  0,003  VCAM1 expression inhibitor
0,661  0,005  Apoptosis antagonist
0,662  0,007  Hepatic disorders treatment
0,660  0,008  Antiparasitic
0,655  0,005  UDP-glucuronosyltransferase substrate
0,661  0,012  Antibacterial
0,661  0,014  Carcinogenic
0,649  0,001  Triose-phosphate isomerase inhibitor
0,650  0,004  Interleukin agonist
0,648  0,004  Melanin inhibitor
0,651  0,009  Cytostatic
0,645  0,006  Vasodilator, coronary
0,637  0,002  Antihemorrhagic
0,638  0,011  Analeptic
0,666  0,040  Alpha-glucosidase inhibitor
0,629  0,006  UGT1A1 substrate
0,626  0,005  Vascular (periferal) disease treatment
0,623  0,005  Antihelmintic
0,618  0,009  Nitric oxide antagonist
0,613  0,005  Skin whitener
0,605  0,003  Neurotrophic factor enhancer
0,611  0,010  Immunomodulator
0,600  0,003  UGT2B4 substrate
0,603  0,009  Antidiabetic (type 2)
0,597  0,005  Hepatoprotectant
0,598  0,009  Antipyretic
0,595  0,006  Antineoplastic (osteosarcoma)
0,603  0,016  Vasodilator, peripheral
0,590  0,003  Protein kinase stimulant
0,589  0,004  Interleukin 2 agonist
0,586  0,001  Mannosidase inhibitor
0,589  0,004  ICAM1 expression inhibitor
0,586  0,002  NADH dehydrogenase inhibitor
0,604  0,020  CYP2C9 substrate
0,587  0,005  Septic shock treatment
0,596  0,015  Radioprotector
0,583  0,005  Antihypertriglyceridemic
0,589  0,013  Antipruritic, allergic
0,580  0,008  DNA synthesis inhibitor
0,600  0,029  CYP3A4 substrate
0,568  0,001  Alpha-mannosidase inhibitor
0,584  0,019  Immunostimulant
0,568  0,003  Carcinogenic, group 1
0,552  0,002  UDP-glucose 4-epimerase inhibitor
0,553  0,004  Mediator release inhibitor
0,558  0,010  DNA damaging
0,549  0,003  Carcinogenic, group 2A
0,564  0,018  Immunosuppressant
0,549  0,010  Tumour necrosis factor alpha release inhibitor
0,556  0,017  Cytotoxic
0,540  0,002  Selectin antagonist
0,551  0,014  Caspase 3 stimulant
0,541  0,005  NOS3 expression enhancer
0,546  0,014  Antifungal
0,561  0,029  Antileukemic
0,548  0,019  Stroke treatment
0,525  0,009  Antineoplastic (lymphoma)
0,509  0,004  Aldehyde dehydrogenase inhibitor
0,506  0,003  Hexokinase inhibitor
0,505  0,004  Expectorant
0,506  0,010  Myocardial infarction treatment
0,489  0,007  Interferon gamma antagonist
0,486  0,004  Antifungal enhancer
0,488  0,009  Radiosensitizer
0,485  0,009  Antineoplastic (sarcoma)
0,484  0,008  Antiviral (Herpes)
0,481  0,006  Platelet adhesion inhibitor
0,478  0,003  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,491  0,021  Antineoplastic (brain cancer)
0,473  0,003  Antineoplastic, alkylator
0,496  0,028  CYP2C19 substrate
0,485  0,022  Antiischemic
0,469  0,010  Anesthetic general
0,461  0,005  Acute respiratory distress syndrome (ARDS) treatment
0,491  0,035  5 Hydroxytryptamine release inhibitor
0,461  0,005  Alkylator
0,458  0,005  Hemostatic
0,449  0,004  Cyclooxygenase 3 inhibitor
0,458  0,016  Antidiabetic symptomatic
0,445  0,005  Antitussive
0,442  0,004  AMP-activated protein kinase stimulant
0,439  0,004  Antispirochetal
0,443  0,009  Antihypotensive
0,448  0,014  RNA-directed DNA polymerase inhibitor
0,438  0,006  Antipruritic, non-allergic
0,434  0,003  Phosphofructokinase-1 inhibitor
0,457  0,035  Ulceration
0,429  0,008  Lipid peroxidase inhibitor
0,478  0,062  Antiarthritic
0,426  0,011  Non-steroidal antiinflammatory agent
0,417  0,003  Nitric-oxide synthase stimulant
0,443  0,030  AR expression inhibitor
0,443  0,030  Lipoprotein disorders treatment
0,415  0,004  Antihelmintic (Nematodes)
0,409  0,001  Sodium/glucose cotransporter inhibitor
0,438  0,030  Antineoplastic (pancreatic cancer)
0,410  0,007  Antidote
0,407  0,005  Topoisomerase I inhibitor
0,408  0,010  Antiviral (Influenza)
0,401  0,003  DNA repair enzyme inhibitor
0,400  0,004  Carbonic anhydrase XIII inhibitor
0,416  0,020  Vasodilator
0,401  0,007  Peptidyltransferase inhibitor
0,398  0,003  Antiviral (Influenza B)
0,465  0,071  Antineoplastic (solid tumors)
0,396  0,003  Photosensitizer
0,398  0,006  Glutathione S-transferase substrate
0,403  0,016  Cyclic AMP phosphodiesterase inhibitor
0,389  0,009  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,384  0,005  Xanthine oxidase inhibitor
0,435  0,057  Histamine release inhibitor
0,378  0,006  Psychosexual dysfunction treatment
0,395  0,024  Antineoplastic (liver cancer)
0,389  0,020  Sedative
0,368  0,005  Neuropathy treatment
0,369  0,008  Antidiabetic (type 1)
0,367  0,007  Cell wall synthesis inhibitor
0,363  0,004  Mannose-6-phosphate isomerase inhibitor
0,359  0,011  Muscular dystrophy treatment
0,361  0,013  Phospholipase C inhibitor
0,355  0,008  Insulin secretagoues
0,389  0,042  Spasmolytic
0,350  0,017  Thrombolytic
0,368  0,037  Antiprotozoal (Leishmania)
0,334  0,004  Antiviral (Ebola)
0,333  0,003  Phosphorylase inhibitor
0,359  0,030  Antineoplastic (small cell lung cancer)
0,371  0,043  Metabolic disease treatment
0,358  0,032  UGT1A6 substrate
0,325  0,003  Glutamate release inhibitor
0,333  0,015  Acaricide
0,352  0,035  Hypolipemic
0,322  0,005  ATPase inhibitor
0,319  0,003  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,368  0,052  Antineoplastic (ovarian cancer)
0,324  0,011  Antidiarrheal
0,393  0,082  Antineoplastic (breast cancer)
0,318  0,009  Cell adhesion inhibitor
0,333  0,028  Wound healing agent
0,317  0,013  Interleukin 6 antagonist
0,322  0,017  Restenosis treatment
0,309  0,006  Beta glucuronidase inhibitor
0,322  0,019  Diabetic retinopathy treatment
0,305  0,003  Interferon agonist
0,310  0,009  Antineoplastic antibiotic
0,316  0,016  Topoisomerase II inhibitor
0,338  0,039  Antineoplastic (endocrine cancer)
0,320  0,023  DNA methylase inhibitor
0,300  0,004  Transcription factor NF kappa B stimulant
0,302  0,007  Dementia treatment
0,300  0,007  Vascular dementia treatment
0,292  0,001  Sodium/glucose cotransporter 2 inhibitor
0,333  0,043  Antiamyloidogenic
0,305  0,016  Diabetic nephropathy treatment
0,305  0,016  Liver fibrosis treatment
0,289  0,001  Sodium/glucose cotransporter 1 inhibitor
0,293  0,005  Choleretic
0,336  0,050  Hypoxia-inducible factor 1 alpha inhibitor
0,290  0,006  Antifungal (Cryptococcus)
0,364  0,081  Antiobesity
0,348  0,066  Prostate cancer treatment
0,346  0,067  Antineoplastic (colorectal cancer)
0,283  0,006  Carbonic anhydrase III inhibitor
0,294  0,017  Antiviral (Influenza A)
0,281  0,004  CF transmembrane conductance regulator agonist
0,338  0,062  CYP2D6 substrate
0,279  0,003  Phosphodiesterase 6D inhibitor
0,336  0,061  Antimycobacterial
0,315  0,042  Amyloid beta aggregation inhibitor
0,297  0,024  Antialcoholic
0,294  0,022  Antineoplastic (squamous cell carcinoma)
0,291  0,021  Hair growth stimulant
0,285  0,017  Cystic fibrosis treatment
0,271  0,005  Mucolytic
0,294  0,029  Eye irritation, high
0,339  0,083  Antineoplastic (lung cancer)
0,329  0,074  Bone diseases treatment
0,305  0,056  Antineoplastic (cervical cancer)
0,257  0,009  Retinoprotector
0,281  0,034  DNA methyltransferase I inhibitor
0,291  0,046  Antiulcerative
0,245  0,001  Glucose-6-phosphate isomerase inhibitor
0,335  0,093  GST A substrate
0,254  0,013  Carcinogenic, group 2B
0,281  0,040  Antiviral (HIV)
0,256  0,016  DNA polymerase I inhibitor
0,242  0,004  Carbonic anhydrase XIV inhibitor
0,293  0,055  Platelet antagonist
0,242  0,006  Vanilloid 1 agonist
0,260  0,026  Carcinogenic, group 3
0,243  0,009  Antirickettsial
0,333  0,100  Atherosclerosis treatment
0,299  0,067  Antiosteoporotic
0,294  0,062  Huntington's disease treatment
0,241  0,009  Carbonic anhydrase VI inhibitor
0,246  0,016  Cystathionine beta-synthase inhibitor
0,304  0,074  Antineoplastic (colon cancer)
0,234  0,004  Toll-Like receptor 4 antagonist
0,231  0,003  Antiviral (Dengue virus)
0,233  0,005  Thioredoxin inhibitor
0,230  0,003  Antibiotic Glycopeptide-like
0,230  0,003  Interferon inducer
0,298  0,071  Antineoplastic (melanoma)
0,257  0,031  Insulin sensitizer
0,228  0,002  Heparanase inhibitor
0,245  0,020  Adenylate cyclase inhibitor
0,230  0,005  Sphingomyelinase inhibitor
0,282  0,062  GST M1-1 substrate
0,227  0,008  Antihelmintic (Trematoda)
0,227  0,007  Hearing loss treatment
0,237  0,020  Antiprotozoal (Coccidial)
0,231  0,014  Antiviral (Poxvirus)
0,280  0,064  Antineoplastic (glioma)
0,256  0,040  UGT2B7 substrate
0,221  0,007  Chronic obstructive bronchitis treatment
0,217  0,005  Histone deacetylase SIRT1 stimulant
0,217  0,005  Histone deacetylase stimulant
0,216  0,005  Interleukin 12 antagonist
0,217  0,008  Adenylate cyclase stimulant
0,239  0,033  Antineoplastic (gastric cancer)
0,282  0,077  Antineoplastic (multiple myeloma)
0,213  0,012  Antibiotic
0,240  0,038  Sepsis treatment
0,262  0,061  Antineoplastic (lymphocytic leukemia)
0,242  0,044  Antiviral (West Nile virus)
0,232  0,035  Antineoplastic (carcinoma)
0,202  0,006  Heat shock protein 70 antagonist
0,215  0,020  Antineoplastic antimetabolite
0,228  0,034  Antiacne
0,299  0,105  Antineoplastic (non-Hodgkin's lymphoma)
0,264  0,071  Antineoplastic (non-small cell lung cancer)
0,224  0,034  UGT2B15 substrate
0,192  0,003  Gaucher disease treatment
0,216  0,028  Uterine stimulant
0,286  0,100  Angiogenesis inhibitor
0,248  0,063  Antineoplastic (glioblastoma multiforme)
0,208  0,023  DNA intercalator
0,200  0,015  Topoisomerase II alpha inhibitor
0,200  0,016  UGT2B1 substrate
0,226  0,043  Antiviral (Hepatitis)
0,208  0,026  Antiviral (Hepatitis B)
0,210  0,030  UGT2B10 substrate
0,197  0,018  Anticataract
0,180  0,003  Antimycoplasmal
0,179  0,004  Glucosylceramidase inhibitor
0,177  0,004  Glycine receptor antagonist
0,248  0,080  Antineoplastic (renal cancer)
0,170  0,002  Cholesterol absorption inhibitor
0,187  0,019  Alcohol dehydrogenase substrate
0,196  0,032  SULT1A3 substrate
0,293  0,129  Antiprotozoal
0,174  0,010  Ca2+-transporting ATPase inhibitor
0,169  0,007  Restless leg syndrome treatment
0,190  0,028  Toll-Like receptor 2 antagonist
0,184  0,022  Growth stimulant
0,161  0,004  Na+ K+ transporting ATPase inhibitor
0,159  0,006  Protein 50S ribosomal subunit inhibitor
0,182  0,029  Interleukin 4 antagonist
0,171  0,020  Adenylate kinase inhibitor
0,177  0,026  Microtubule formation inhibitor
0,207  0,059  Myocardial ischemia treatment
0,161  0,013  Antifungal (Pneumocystis)
0,153  0,006  Phosphodiesterase VI inhibitor
0,163  0,017  Alcohol dehydrogenase inhibitor
0,150  0,007  Antiviral (Herpesvirus 3, Human)
0,237  0,096  Gastrin inhibitor
0,146  0,008  ATPase (Vacuolar H+) inhibitor
0,154  0,019  Actinic keratosis treatment
0,141  0,008  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,146  0,014  Antiviral (Rhinovirus)
0,238  0,109  CYP1A2 substrate
0,135  0,008  Narcotic antagonist
0,128  0,002  Antibiotic Aminoglycoside-like
0,154  0,029  Constipation treatment
0,271  0,145  Antineoplastic (myeloid leukemia)
0,147  0,023  Neutropenia treatment
0,170  0,047  Renal failure treatment
0,146  0,024  Uric acid excretion stimulant
0,157  0,036  Beta amyloid protein antagonist
0,120  0,002  Uridine phosphorylase inhibitor
0,147  0,030  Aldehyde dehydrogenase substrate
0,189  0,074  Growth factor agonist
0,128  0,013  GABA aminotransferase inhibitor
0,149  0,035  Antischistosomal
0,289  0,177  Alzheimer's disease treatment
0,134  0,023  UGT2B11 substrate
0,113  0,004  Cytokine production stimulant
0,122  0,014  T cell inhibitor
0,172  0,064  Antiviral (Hepatitis C)
0,141  0,035  Falcipain inhibitor
0,141  0,035  HDL-cholesterol increasing
0,108  0,002  Ceramide glucosyltransferase inhibitor
0,138  0,034  Falcipain 2 inhibitor
0,112  0,008  Topoisomerase II beta inhibitor
0,169  0,067  Anticoagulant
0,118  0,016  Carbamoyl phosphate synthetase inhibitor
0,150  0,049  Antihyperlipoproteinemic
0,115  0,015  Aldose reductase inhibitor
0,103  0,003  Protein 30S ribosomal subunit inhibitor
0,147  0,048  Skin irritative effect
0,172  0,074  Antineoplastic (bone cancer)
0,191  0,094  Antineoplastic enhancer
0,166  0,070  Arachidonic acid antagonist
0,120  0,024  Interleukin 5 antagonist
0,101  0,006  Glucose-6-phosphate translocase inhibitor
0,121  0,026  Antiviral (Trachoma)
0,145  0,050  Antibacterial (Helicobacter pylori)
0,160  0,067  UGT2B9 substrate
0,125  0,033  Arylamine N-Acetyltransferase substrate
0,104  0,013  Antitreponemal
0,121  0,030  Aminoacyl-tRNA synthetase inhibitor
0,181  0,090  Osteoarthritis treatment
0,106  0,019  Carbonic anhydrase XII inhibitor
0,125  0,039  Antiprotozoal (Toxoplasma)
0,101  0,016  Antimetabolite
0,164  0,080  Muscle relaxant
0,099  0,016  Antidote, heavy metal
0,146  0,063  Neurotrophic factor
0,090  0,007  Adenosine deaminase inhibitor
0,129  0,048  Gout treatment
0,082  0,001  Vanilloid 2 agonist
0,109  0,029  Cell adhesion molecule inhibitor
0,097  0,018  Purinergic P2X1 antagonist
0,080  0,003  Guanylate cyclase inhibitor
0,142  0,066  Alkaline phosphatase inhibitor
0,168  0,092  P-glycoprotein inhibitor
0,125  0,051  Antiviral (CMV)
0,125  0,052  SULT1A1 substrate
0,096  0,023  Prokinetic
0,093  0,021  Biliverdin reductase inhibitor
0,078  0,007  Equilibrative nucleoside transport protein inhibitor
0,101  0,030  Glutamate dehydrogenase inhibitor
0,079  0,009  Adenine nucleotide translocase inhibitor
0,114  0,045  Anabolic
0,169  0,100  Psychostimulant
0,083  0,015  Factor IXa inhibitor
0,216  0,150  CTGF expression inhibitor
0,066  0,003  Ileal bile acid transport inhibitor
0,224  0,161  FMO1 substrate
0,090  0,028  Glycine receptor agonist
0,082  0,020  Nitric oxide donor
0,084  0,023  Neuraminidase (influenza) inhibitor
0,205  0,143  5 Hydroxytryptamine uptake stimulant
0,085  0,024  Prostaglandin EP2 antagonist
0,071  0,010  Factor III inhibitor
0,069  0,008  Arginase inhibitor
0,123  0,062  Cholesterol synthesis inhibitor
0,083  0,022  Estrogen agonist
0,257  0,197  Calcium channel L-type activator
0,197  0,137  Transcription factor STAT3 inhibitor
0,069  0,010  Phosphoglycerate kinase inhibitor
0,109  0,050  Antifibrinolytic
0,062  0,006  Nucleoside transporters inhibitor
0,126  0,070  Antineoplastic (uterine cancer)
0,081  0,026  Carbonic anhydrase IX inhibitor
0,129  0,073  Toll-Like receptor antagonist
0,162  0,107  Abortion inducer
0,101  0,046  Paget's disease treatment
0,079  0,026  Argininosuccinate synthase inhibitor
0,089  0,035  Lipase inhibitor
0,054  0,001  Telomerase stimulant
0,113  0,060  Excitatory amino acid transporter EAAC1 inhibitor
0,117  0,065  Protein-tyrosine phosphatase 1B inhibitor
0,108  0,058  GST T1-1 substrate
0,114  0,065  TRPA1 agonist
0,062  0,013  Thymidine kinase inhibitor
0,092  0,043  Vanilloid agonist
0,102  0,053  Lanosterol 14 alpha demethylase inhibitor
0,065  0,017  Squalene epoxidase inhibitor
0,077  0,029  SULT2A1 substrate
0,096  0,049  Ornithine decarboxylase inhibitor
0,127  0,081  CC chemokine 6 receptor antagonist
0,049  0,004  GRP78 expression inhibitor
0,132  0,087  Skeletal muscle relaxant
0,072  0,030  Hypercalcemia treatment
0,069  0,027  Acyl-CoA dehydrogenase inhibitor
0,066  0,025  Lipocortins synthesis agonist
0,063  0,024  Leukotriene B4 antagonist
0,043  0,004  Toll-Like receptor 4 agonist
0,109  0,071  Interleukin 1b antagonist
0,116  0,077  Contraceptive female
0,041  0,002  Antibiotic Anthracycline-like
0,134  0,096  Protein-tyrosine phosphatase inhibitor
0,070  0,033  Neuraminidase inhibitor
0,085  0,049  Thioredoxin reductase inhibitor
0,046  0,012  Melatonin 2 agonist
0,071  0,037  Andropause treatment
0,188  0,155  Transcription factor STAT inhibitor
0,055  0,022  Carbonic anhydrase VII inhibitor
0,040  0,008  Adenosine A1 receptor agonist
0,043  0,011  Hypoxanthine phosphoribosyltransferase inhibitor
0,087  0,056  Antileprosy
0,036  0,005  1,3-Beta-glucan synthase inhibitor
0,077  0,048  Adenosine A3 receptor antagonist
0,069  0,040  Antihemophilic
0,064  0,035  Xanthine dehydrogenase inhibitor
0,051  0,023  Toll-Like receptor 2 agonist
0,034  0,007  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,053  0,026  Cholesterol esterase inhibitor
0,043  0,017  Fumarate hydratase inhibitor
0,034  0,009  Thymidine phosphorylase inhibitor
0,058  0,034  Postmenopausal disorders treatment
0,094  0,070  Antifungal (Candida)
0,029  0,006  Isoleucine-tRNA ligase inhibitor
0,129  0,107  Antinephritic
0,050  0,028  Microtubule stabilization
0,045  0,023  Hypogonadism treatment
0,110  0,088  Antiprotozoal (Amoeba)
0,126  0,105  UGT1A4 substrate
0,057  0,037  Peristaltic stimulant
0,063  0,044  Carbonic anhydrase inhibitor
0,063  0,044  HIV-1 integrase (3'-Processing) inhibitor
0,029  0,010  Motilin receptor agonist
0,061  0,041  HIV-1 integrase (Strand Transfer) inhibitor
0,068  0,050  Anticholelithogenic
0,070  0,051  Histidine decarboxylase inhibitor
0,036  0,019  Adenosine uptake inhibitor
0,062  0,045  Antiviral (Parainfluenza)
0,022  0,005  O6-alkylguanine-DNA alkyltransferase inhibitor
0,101  0,085  Acetylcholine release stimulant
0,018  0,002  Purinergic P2Y2 agonist
0,093  0,078  Carbonic anhydrase XV inhibitor
0,211  0,197  Calcium channel activator
0,096  0,083  Chelator
0,139  0,125  Cardiodepressant
0,020  0,007  Antibiotic Macrolide-like
0,102  0,090  Myasthenia Gravis treatment
0,022  0,010  Apical sodium codependent bile acid transporter inhibitor
0,141  0,130  Succinate dehydrogenase inhibitor
0,101  0,092  Menstruation disorders treatment
0,076  0,067  Glutathione S-transferase inhibitor
0,017  0,008  Purinergic P2Y1 agonist
0,066  0,057  Protein kinase C beta inhibitor
0,017  0,009  Purinergic P2 agonist
0,017  0,009  Purinergic receptor agonist
0,117  0,108  Diuretic
0,150  0,142  Pneumotoxic
0,023  0,015  Dopamine D1 agonist
0,043  0,036  Neuraminidase (Influenza A) inhibitor
0,052  0,044  Sphingosine kinase 2 inhibitor
0,017  0,010  Adenosine A2 receptor agonist
0,016  0,009  Adenosine A2a receptor agonist
0,015  0,009  S-adenosyl-L-homocysteine hydrolase inhibitor
0,020  0,014  Inosine monophosphate dehydrogenase 1 inhibitor
0,201  0,196  Inflammatory Bowel disease treatment
0,013  0,008  Purinergic P2Y agonist
0,167  0,162  Antituberculosic
0,096  0,092  Nav1.5 sodium channel blocker
0,017  0,012  Adenosine A3 receptor agonist
0,196  0,193  Sodium/bile acid cotransporter inhibitor
0,032  0,029  Protein kinase C beta I inhibitor
0,051  0,049  Fatty acid synthase inhibitor
0,004  0,002  Purinergic P2Y6 agonist
0,054  0,052  Sphingosine kinase inhibitor
0,013  0,012  Adenosine A2b receptor agonist
0,048  0,047  Protein kinase C eta inhibitor

